<DOC>
	<DOCNO>NCT00721422</DOCNO>
	<brief_summary>1 . To investigate effect kidney function elimination single dose PD 0332334 body . 2 . To investigate safety tolerability single dose PD 0332334 patient impaired kidney function .</brief_summary>
	<brief_title>A Single Dose Study Investigating Elimination Well Tolerability PD 0332334 Healthy Subjects Compared Patients With Impaired Kidney Function .</brief_title>
	<detailed_description>Additional Study Purpose Details : Investigation pharmacokinetics , safety , tolerability single dose PD 0332334 patient impaired renal function . On February 23rd 2009 , decision terminate development PD 0332334 communicate investigator study . The decision terminate study base safety concern .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>Healthy volunteer OR subject kidney impairment 1 . Receiving hemodialysis 2. clinically significant unstable medical disease kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Pharmacokinetics PD 0332334 subject renal insufficiency</keyword>
</DOC>